NEW YORK ( TheStreet) -- Biosante Pharmaceuticals (Nasdaq: BPAX) is trading at unusually high volume Tuesday with 21 million shares changing hands. It is currently at 4.2 times its average daily volume and trading down 10 cents (-9.5%) at 95 cents as of 10:40 a.m. ET. Biosante has a market cap of $72.2 million and is part of the health care sector and drugs industry. Shares are up 109.1% year to date as of the close of trading on Monday. BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. TheStreet Ratings rates Biosante as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full Biosante Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center. Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.
More from Markets
Why Stocks Are Rising After Trump's 'Nothing New' Speech at Economic Club
Some say stock investors have grown more optimistic. Some say there's just nowhere else for money to flow. In any event, take the recent rally with a grain of salt, one manager says.
Nasdaq Closes at Record, Dow Flat as Trump Teases China Trade Pact, Slams Fed
Stocks ended mixed with the Nasdaq closing at a new high, while the Dow and S&P 500 gave back earlier gains to end little changed Tuesday.
Trump Continues Denouncing Fed Actions -- How Should Retail Investors React?
Here's how retail investors should process the president's bashing of the Federal Reserve.